118 related articles for article (PubMed ID: 12733434)
1. In vitro conversion of normal prion protein into pathologic isoforms.
Bossers A; Rigter A; de Vries R; Smits MA
Clin Lab Med; 2003 Mar; 23(1):227-47. PubMed ID: 12733434
[TBL] [Abstract][Full Text] [Related]
2. Prion protein self-interactions: a gateway to novel therapeutic strategies?
Rigter A; Langeveld JP; van Zijderveld FG; Bossers A
Vaccine; 2010 Nov; 28(49):7810-23. PubMed ID: 20932496
[TBL] [Abstract][Full Text] [Related]
3. Glycosylation influences cross-species formation of protease-resistant prion protein.
Priola SA; Lawson VA
EMBO J; 2001 Dec; 20(23):6692-9. PubMed ID: 11726505
[TBL] [Abstract][Full Text] [Related]
4. Chaperone-supervised conversion of prion protein to its protease-resistant form.
DebBurman SK; Raymond GJ; Caughey B; Lindquist S
Proc Natl Acad Sci U S A; 1997 Dec; 94(25):13938-43. PubMed ID: 9391131
[TBL] [Abstract][Full Text] [Related]
5. Generation of genuine prion infectivity by serial PMCA.
Weber P; Giese A; Piening N; Mitteregger G; Thomzig A; Beekes M; Kretzschmar HA
Vet Microbiol; 2007 Aug; 123(4):346-57. PubMed ID: 17493773
[TBL] [Abstract][Full Text] [Related]
6. Species barrier in prion diseases: a kinetic interpretation based on the conformational adaptation of the prion protein.
Kellershohn N; Laurent M
Biochem J; 1998 Sep; 334 ( Pt 3)(Pt 3):539-45. PubMed ID: 9729459
[TBL] [Abstract][Full Text] [Related]
7. Molecular assessment of the potential transmissibilities of BSE and scrapie to humans.
Raymond GJ; Hope J; Kocisko DA; Priola SA; Raymond LD; Bossers A; Ironside J; Will RG; Chen SG; Petersen RB; Gambetti P; Rubenstein R; Smits MA; Lansbury PT; Caughey B
Nature; 1997 Jul; 388(6639):285-8. PubMed ID: 9230438
[TBL] [Abstract][Full Text] [Related]
8. Unraveling the details of prion (con)formation(s): recent advances by mass spectrometry.
Principe S; Maras B; Schininà ME; Pocchiari M; Cardone F
Curr Opin Drug Discov Devel; 2008 Sep; 11(5):697-707. PubMed ID: 18729021
[TBL] [Abstract][Full Text] [Related]
9. Sulfated glycans and elevated temperature stimulate PrP(Sc)-dependent cell-free formation of protease-resistant prion protein.
Wong C; Xiong LW; Horiuchi M; Raymond L; Wehrly K; Chesebro B; Caughey B
EMBO J; 2001 Feb; 20(3):377-86. PubMed ID: 11157745
[TBL] [Abstract][Full Text] [Related]
10. Soluble dimeric prion protein binds PrP(Sc) in vivo and antagonizes prion disease.
Meier P; Genoud N; Prinz M; Maissen M; Rülicke T; Zurbriggen A; Raeber AJ; Aguzzi A
Cell; 2003 Apr; 113(1):49-60. PubMed ID: 12679034
[TBL] [Abstract][Full Text] [Related]
11. Insights into Mechanisms of Transmission and Pathogenesis from Transgenic Mouse Models of Prion Diseases.
Moreno JA; Telling GC
Methods Mol Biol; 2017; 1658():219-252. PubMed ID: 28861793
[TBL] [Abstract][Full Text] [Related]
12. The glycosylation status of PrPC is a key factor in determining transmissible spongiform encephalopathy transmission between species.
Wiseman FK; Cancellotti E; Piccardo P; Iremonger K; Boyle A; Brown D; Ironside JW; Manson JC; Diack AB
J Virol; 2015 May; 89(9):4738-47. PubMed ID: 25673720
[TBL] [Abstract][Full Text] [Related]
13. Towards cellular receptors for prions.
Lee KS; Linden R; Prado MA; Brentani RR; Martins VR
Rev Med Virol; 2003; 13(6):399-408. PubMed ID: 14625887
[TBL] [Abstract][Full Text] [Related]
14. Prion protein conversion in vitro.
Supattapone S
J Mol Med (Berl); 2004 Jun; 82(6):348-56. PubMed ID: 15014886
[TBL] [Abstract][Full Text] [Related]
15. Cell-free formation of protease-resistant prion protein.
Kocisko DA; Come JH; Priola SA; Chesebro B; Raymond GJ; Lansbury PT; Caughey B
Nature; 1994 Aug; 370(6489):471-4. PubMed ID: 7913989
[TBL] [Abstract][Full Text] [Related]
16. Prion seeded conversion and amplification assays.
Orrú CD; Caughey B
Top Curr Chem; 2011; 305():121-33. PubMed ID: 21678135
[TBL] [Abstract][Full Text] [Related]
17. Prion protein conversions: insight into mechanisms, TSE transmission barriers and strains.
Caughey B
Br Med Bull; 2003; 66():109-20. PubMed ID: 14522853
[TBL] [Abstract][Full Text] [Related]
18. Evolving views in prion glycosylation: functional and pathological implications.
Ermonval M; Mouillet-Richard S; Codogno P; Kellermann O; Botti J
Biochimie; 2003; 85(1-2):33-45. PubMed ID: 12765773
[TBL] [Abstract][Full Text] [Related]
19. Prion protein glycosylation.
Lawson VA; Collins SJ; Masters CL; Hill AF
J Neurochem; 2005 May; 93(4):793-801. PubMed ID: 15857383
[TBL] [Abstract][Full Text] [Related]
20. Sc237 hamster PrPSc and Sc237-derived mouse PrPSc generated by interspecies in vitro amplification exhibit distinct pathological and biochemical properties in tga20 transgenic mice.
Yoshioka M; Imamura M; Okada H; Shimozaki N; Murayama Y; Yokoyama T; Mohri S
Microbiol Immunol; 2011 May; 55(5):331-40. PubMed ID: 21362027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
